tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AU:PTX Stock Latest News

Prescient Therapeutics Expands PTX-100 Clinical Trials to U.S.
Company AnnouncementsPrescient Therapeutics Expands PTX-100 Clinical Trials to U.S.
4d ago
PTX
Prescient Therapeutics Extends Securities Issue Deadline
PremiumCompany Announcements
Prescient Therapeutics Extends Securities Issue Deadline
4d ago
PTX
Prescient Therapeutics Extends Share Purchase Plan to Advance Cancer Treatment Development
PremiumCompany Announcements
Prescient Therapeutics Extends Share Purchase Plan to Advance Cancer Treatment Development
5d ago
PTX
Prescient Therapeutics Announces Cessation of Securities
PremiumCompany Announcements
Prescient Therapeutics Announces Cessation of Securities
5d ago
PTX
Prescient Therapeutics Announces Cessation of Securities
PremiumCompany Announcements
Prescient Therapeutics Announces Cessation of Securities
11d ago
PTX
Prescient Therapeutics Announces Shareholder Briefing and Advances in Cancer Therapies
PremiumCompany AnnouncementsPrescient Therapeutics Announces Shareholder Briefing and Advances in Cancer Therapies
15d ago
PTX
Prescient Therapeutics Launches Share Purchase Plan to Fund Cancer Therapy Development
Premium
Company Announcements
Prescient Therapeutics Launches Share Purchase Plan to Fund Cancer Therapy Development
18d ago
PTX
Prescient Therapeutics Launches $7 Million Share Purchase Plan
Premium
Company Announcements
Prescient Therapeutics Launches $7 Million Share Purchase Plan
18d ago
PTX
Prescient Therapeutics Announces Securities Issue to Boost Cancer Research
PremiumCompany Announcements
Prescient Therapeutics Announces Securities Issue to Boost Cancer Research
18d ago
PTX
Prescient Therapeutics Launches $7 Million Share Purchase Plan to Advance Cancer Therapy
PremiumCompany Announcements
Prescient Therapeutics Launches $7 Million Share Purchase Plan to Advance Cancer Therapy
18d ago
PTX
Prescient Therapeutics Announces New Office Location Amidst Strategic Growth
PremiumCompany Announcements
Prescient Therapeutics Announces New Office Location Amidst Strategic Growth
2M ago
PTX
Prescient Therapeutics Advances with Phase 2A Trial of PTX-100
PremiumCompany Announcements
Prescient Therapeutics Advances with Phase 2A Trial of PTX-100
2M ago
PTX
Prescient Therapeutics Advances PTX-100 in Phase 2a Study for CTCL
PremiumCompany AnnouncementsPrescient Therapeutics Advances PTX-100 in Phase 2a Study for CTCL
2M ago
PTX
Prescient Therapeutics Highlights Forward-Looking Risks in Cancer Therapy Development
Premium
Company Announcements
Prescient Therapeutics Highlights Forward-Looking Risks in Cancer Therapy Development
2M ago
PTX
Prescient Therapeutics Director Increases Stake
Premium
Company Announcements
Prescient Therapeutics Director Increases Stake
2M ago
PTX
Director’s Acquisition Signals Confidence in Prescient Therapeutics
PremiumCompany Announcements
Director’s Acquisition Signals Confidence in Prescient Therapeutics
3M ago
PTX
Prescient Therapeutics Advances PTX-100 Study and Appoints New Board Chair
PremiumCompany Announcements
Prescient Therapeutics Advances PTX-100 Study and Appoints New Board Chair
3M ago
PTX
Prescient Therapeutics Advances Cancer Therapy with FDA Fast Track
PremiumCompany Announcements
Prescient Therapeutics Advances Cancer Therapy with FDA Fast Track
3M ago
PTX
Prescient Therapeutics’ PTX-100 Gains FDA Fast Track Status
PremiumCompany Announcements
Prescient Therapeutics’ PTX-100 Gains FDA Fast Track Status
3M ago
PTX
Prescient Therapeutics Appoints Melanie Farris as Non-Executive Director
PremiumCompany AnnouncementsPrescient Therapeutics Appoints Melanie Farris as Non-Executive Director
3M ago
PTX
Prescient Therapeutics to Host Investor Briefing on PTX-100 Progress
Premium
Company Announcements
Prescient Therapeutics to Host Investor Briefing on PTX-100 Progress
4M ago
PTX
Prescient Therapeutics Initiates First Clinical Site for PTX-100 Phase 2a Study
Premium
Company Announcements
Prescient Therapeutics Initiates First Clinical Site for PTX-100 Phase 2a Study
4M ago
PTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >